Status:
COMPLETED
Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients
Lead Sponsor:
Istanbul University
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Investigators predict that the information that can be obtained in terms of renal functions before clinical development in sepsis patients can be valuable in terms of guiding treatment algorithms, pla...
Detailed Description
Despite the developments in Intensive Care Units (ICU), mortality and morbidity rates due to sepsis and septic shock are still high and it is seen as one of the major causes of death in ICU patients. ...
Eligibility Criteria
Inclusion
- Patients diagnosed with sepsis and septic shock according to the "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)" guideline.
- Signing of the Informed Consent Form by the patient or his legal representative.
Exclusion
- Patients under 18 years of age.
- They are pregnant.
- Malignant patients in the terminal period with no expected survival.
- The Informed Consent Form is not signed by the patient or patient's relative.
- Sepsis and septic shock patients admitted from another hospital under vasopressor or on mechanical ventilator.
- Patients who develop brain damage and multi-organ failure after cardiopulmonary resuscitation.
- Chronic renal failure patients receiving dialysis treatment.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2022
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05310812
Start Date
December 1 2021
End Date
November 29 2022
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University, Istanbul Faculy of Medicine
Istanbul, Turkey (Türkiye), 34093